ZNF312, also known by its gene name FEZF2 (FEZ family zinc finger 2), is a transcription factor that plays a significant role in the development of the nervous system. It is particularly noteworthy for its involvement in the differentiation of specific neuron subtypes within the cerebral cortex. ZNF312 is a protein that helps to orchestrate the complex gene expression programs necessary for the development and specialization of neural cells. The exact regulation of ZNF312 is subject to a multitude of factors, including intracellular signaling pathways, transcriptional networks, and epigenetic modifications that collectively contribute to its expression pattern. An understanding of the molecules that can induce the expression of ZNF312 is pivotal for unraveling the intricate web of gene regulation in neuronal development.
Several chemical compounds, each with unique mechanisms of action, have been hypothesized to stimulate the expression of the ZNF312 protein. For instance, compounds like retinoic acid and tretinoin are known for their roles in cell differentiation and could upregulate ZNF312 by binding to nuclear receptors, thereby promoting transcriptional activation of genes involved in neurogenesis. Histone deacetylase inhibitors such as trichostatin A, sodium butyrate, and valproic acid may induce ZNF312 expression by altering chromatin structure, leading to a transcriptionally permissive state that favors gene expression. Likewise, DNA methyltransferase inhibitors, specifically 5-Azacytidine, could stimulate ZNF312 transcription through DNA demethylation, enhancing gene accessibility. Additionally, signaling modulators like forskolin, which increases cellular cAMP levels, and lithium chloride, with its action on GSK-3β, may indirectly lead to an upsurge in ZNF312 expression by activating downstream transcription factors. These chemical activators represent a spectrum of molecules that, through diverse pathways, can orchestrate the transcriptional activation of ZNF312, thus shedding light on the molecular intricacies governing neural cell fate determination.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid could upregulate ZNF312 by binding to retinoic acid receptors, which might stimulate the transcription of neuronal differentiation genes. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This DNA methyltransferase inhibitor could induce ZNF312 expression by DNA demethylation, thereby enhancing the transcription of genes involved in neurogenesis. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A may upregulate ZNF312 by inhibiting histone deacetylases, leading to a more open chromatin configuration and increased transcriptional activity. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium might stimulate ZNF312 expression through the inhibition of GSK-3β, potentially resulting in the activation of Wnt signaling and transcriptional changes. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
By elevating cAMP levels, forskolin could stimulate the activation of CREB, a transcription factor that may increase ZNF312 transcription as part of a cascade of gene activation. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate may promote the upregulation of ZNF312 by inhibiting histone deacetylase, leading to hyperacetylation of histones and enhanced gene expression. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Valproic acid could increase ZNF312 levels by inhibiting histone deacetylase, similar to sodium butyrate, creating an environment conducive to gene transcription. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP may induce ZNF312 by mimicking cAMP and activating protein kinase A, which can phosphorylate transcription factors and stimulate gene expression. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
β-Estradiol could stimulate ZNF312 transcription by engaging estrogen receptors that interact with DNA response elements linked to gene upregulation. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
SB 431542 might induce the expression of ZNF312 by inhibiting TGF-beta signaling, which may relieve inhibitory control on neuronal gene transcription programs. | ||||||